Announced
Completed
Otium Capital led a €16m Series A round in BeFC Bioenzymatic.
Synopsis
Otium Capital, an investment company, led a €16m Series A round in BeFC Bioenzymatic, a renewable energy semiconductor manufacturing, with participation from Demeter, BNP Paribas Développement and Supernova Invest.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Seller Team (3)
Bidder Team (2)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite